Ondansetron Tablet, Orally Disintegrating
Product Images NDC 55154-4567

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-4567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

26aff90c 49ea 46ac Bbf3 C188c2b061c9

This is a description of Ondansetron Orally Disintegrating Tablets. Each tablet contains 4 mg ondansetron, USP and is intended for institutional use only. The package warns to keep all drugs out of reach of children and not to remove tablets from the blister pack until immediately before use. The product disintegrates in approximately 60 seconds and should not be used if the blister is torn, broken, or missing. The usual dose and storage instructions are available in the product insert. The tablets are manufactured by Sun Pharmaceutical Industries Ltd. in Gujarat, India and distributed by Cardinal Health in Dublin, OH.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Spl-ondansetron-chemical-structure (Spl Ondansetron Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.